These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7758465)

  • 21. Kinetics and inhibition of carbonic anhydrase-catalyzed hydrolysis of 2-hydroxy-5-nitro-alpha-toluenesulfonic acid sultone. Comparison with reactions of other substrates.
    Sanyal G; Ferrero JL; Maren TH
    Biochim Biophys Acta; 1983 Apr; 744(2):171-9. PubMed ID: 6404306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional consequences of engineering the hydrophobic pocket of carbonic anhydrase II.
    Fierke CA; Calderone TL; Krebs JF
    Biochemistry; 1991 Nov; 30(46):11054-63. PubMed ID: 1657158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of a metal ligand in carbonic anhydrase: crystal structure of His94-->Glu human isozyme II.
    Xue Y; Jonsson BH; Liljas A; Lindskog S
    FEBS Lett; 1994 Sep; 352(2):137-40. PubMed ID: 7925962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide.
    Huang S; Xue Y; Sauer-Eriksson E; Chirica L; Lindskog S; Jonsson BH
    J Mol Biol; 1998; 283(1):301-10. PubMed ID: 9761692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalysis and inhibition of human carbonic anhydrase IV.
    Baird TT; Waheed A; Okuyama T; Sly WS; Fierke CA
    Biochemistry; 1997 Mar; 36(9):2669-78. PubMed ID: 9054574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
    Chakravarty S; Kannan KK
    J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalysis by mutants of human carbonic anhydrase II: effects of replacing hydrophobic residues 198 and 204.
    Taoka S; Chen X; Tarnuzzer RW; Van Heeke G; Tu C; Silverman DN
    Biochim Biophys Acta; 1992 Oct; 1159(3):274-8. PubMed ID: 1327160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.
    Eriksson AE; Kylsten PM; Jones TA; Liljas A
    Proteins; 1988; 4(4):283-93. PubMed ID: 3151020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of zinc binding functions for carbonic anhydrase inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Curr Pharm Des; 2008; 14(7):615-21. PubMed ID: 18336306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis of inhibitor affinity to variants of human carbonic anhydrase II.
    Nair SK; Krebs JF; Christianson DW; Fierke CA
    Biochemistry; 1995 Mar; 34(12):3981-9. PubMed ID: 7696263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrolysis of 4-nitrophenyl acetate catalyzed by carbonic anhydrase III from bovine skeletal muscle.
    Tu CK; Thomas HG; Wynns GC; Silverman DN
    J Biol Chem; 1986 Aug; 261(22):10100-3. PubMed ID: 3090030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorus versus Sulfur: Discovery of Benzenephosphonamidates as Versatile Sulfonamide-Mimic Chemotypes Acting as Carbonic Anhydrase Inhibitors.
    Nocentini A; Gratteri P; Supuran CT
    Chemistry; 2019 Jan; 25(5):1188-1192. PubMed ID: 30411821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction and influence of phenylalanine-198 and threonine-199 on catalysis by human carbonic anhydrase III.
    Chen X; Tu C; LoGrasso PV; Laipis PJ; Silverman DN
    Biochemistry; 1993 Aug; 32(31):7861-5. PubMed ID: 8347590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of amino acid replacement at position 198 on catalytic properties of zinc-bound water in human carbonic anhydrase III.
    LoGrasso PV; Tu C; Chen X; Taoka S; Laipis PJ; Silverman DN
    Biochemistry; 1993 Jun; 32(22):5786-91. PubMed ID: 8504098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural analysis of inhibitor binding to human carbonic anhydrase II.
    Boriack-Sjodin PA; Zeitlin S; Chen HH; Crenshaw L; Gross S; Dantanarayana A; Delgado P; May JA; Dean T; Christianson DW
    Protein Sci; 1998 Dec; 7(12):2483-9. PubMed ID: 9865942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes.
    Håkansson K; Carlsson M; Svensson LA; Liljas A
    J Mol Biol; 1992 Oct; 227(4):1192-204. PubMed ID: 1433293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization of an efficient carbonic anhydrase: implications for the mechanism based on structure-function studies of a T199P/C206S mutant.
    Huang S; Sjöblom B; Sauer-Eriksson AE; Jonsson BH
    Biochemistry; 2002 Jun; 41(24):7628-35. PubMed ID: 12056894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
    Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
    Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.